Health care stocks were flat to higher premarket Thursday, with The Health Care Select Sector SPDR Fund (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) inactive.
Soleno Therapeutics (SLNO) shares were up 35% after the company said overnight that the US Food and Drug Administration has approved its treatment for hyperphagia in adults and children with Prader-Willi Syndrome, a rare genetic disorder.
Bausch + Lomb (BLCO) stock was more than 4% lower after the company said it is voluntarily recalling the intraocular lenses on its enVista platform after reports of complications.
Ascentage Pharma Group (AAPG) shares were up over 10% after the company reported a narrower 2024 loss as revenue rose during the period.